Latest Breaking News On - Primary immunoglobulin - Page 1 : comparemela.com

Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

STOCKHOLM, May 28, 2024 /PRNewswire/ Calliditas Therapeutics AB , today announced the presentations of an additional efficacy analysis of Nefecon delayed release capsules)) as well as a.

Richard philipsonNasdaq stockholmChief medical officerKidney diseaseImproving global outcomesFull prescribingPrimary immunoglobulin

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Richard philipsonJonathan barrattShikha wadhwaniRichard lafayetteNorthwestern universityEuropean renal associationRenal medicine at leicester universityChief medical officerPoster presentationFocused oral roomClinical markersIga nephropathyRenal medicineFull prescribingPrimary immunoglobulin

Calliditas Therapeutics to Present Data at ERA 2024 May 23

Calliditas Therapeutics to Present Data at ERA 2024 May 23
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Richard philipsonRichard lafayetteJonathan barrattShikha wadhwaniRenal medicine at leicester universityNorthwestern universityEuropean renal associationChief medical officerPoster presentationFocused oral roomClinical markersIga nephropathyRenal medicineFull prescribingPrimary immunoglobulinIhr portfolio

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBonnie schneiderRenee aguiar lucanderRichard lafayetteDrug administrationIgan foundationCompany phaseCalliditas therapeuticsNasdaq stockholmImportant safety informationEnrollment formFull prescribingPrimary immunoglobulin

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 (2)

STOCKHOLM, Oct. 19, 2023 /PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX).

United statesStanford healthcaredateRichard philipsonHong zhangdateThierry christophedateNadia nawazRoisin thomasdateJonathan barrattRichard lafayetteAmerican society of nephrologyUniversity of leicesterdateExhibit hallsbd pennsylvania convention centerPennsylvania convention centerAmerican societyKidney weekPrimary iga